Raptor Pharm (RPTP) Reports Q2 Loss of 20c, Raises PROCYSBI Guidance
Tweet Send to a Friend
Raptor Pharm (NASDAQ: RPTP) reported Q2 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
